title: Persistence in muscle of an adenoviral vector that lacks all viral genes.
abstract: Genetic correction of inherited muscle diseases, such as Duchenne muscular dystrophy, will require long term expression of the recombinant protein following gene transfer. We have shown previously that a new adenoviral vector that lacks all viral genes expressed both full-length dystrophin and beta-galactosidase in mdx (dystrophin-deficient) mouse muscle. We observed a significant histologic improvement of vector-transduced mdx muscle before the eventual loss of vector-encoded transgene expression. In this study, we investigated whether an immunological response against vector-encoded beta-galactosidase contributed to the loss of vector expression and affected vector persistence in muscle. Intramuscular vector injection in control normal mice resulted in an early and complete loss of beta-galactosidase expression accompanied by predominantly CD4+ and CD8+ lymphocytic infiltration and a significant loss of vector DNA. In contrast, intramuscular vector injection in lacZ transgenic mice resulted in persistent expression of beta-galactosidase for at least 84 days with no evidence of inflammation or significant loss of vector DNA. Our studies demonstrate that, in the absence of an immune response induced by beta-galactosidase expression, an adenoviral vector lacking all viral genes is stably maintained in muscle.
authors.affiliation: Department of Neurology, University of Pittsburgh, PA 15213, USA.
authors.forename: H H
authors.initials: HH
authors.lastname: Chen
authors.forename: L M
authors.initials: LM
authors.lastname: Mack
authors.forename: R
authors.initials: R
authors.lastname: Kelly
authors.forename: M
authors.initials: M
authors.lastname: Ontell
authors.forename: S
authors.initials: S
authors.lastname: Kochanek
authors.forename: P R
authors.initials: PR
authors.lastname: Clemens
mesh_terms: D000256:Adenoviridae / Q000235:genetics* / Q000378:metabolism; D000818:Animals; D004279:DNA, Viral / Q000378:metabolism; D016189:Dystrophin / Q000235:genetics / Q000378:metabolism; D005260:Female; D018628:Gene Dosage; D005786:Gene Expression Regulation / Q000235:genetics; D018014:Gene Transfer Techniques; D005814:Genes, Viral / Q000235:genetics*; D015316:Genetic Therapy; D005822:Genetic Vectors / Q000235:genetics*; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D018482:Muscle, Skeletal / Q000378:metabolism; D009137:Muscular Dystrophy, Animal / Q000235:genetics* / Q000628:therapy; D013601:T-Lymphocytes / Q000276:immunology*; D019076:Transgenes / Q000235:genetics; D001616:beta-Galactosidase / Q000235:genetics / Q000276:immunology
chemical_list: D004279:DNA, Viral; D016189:Dystrophin; D001616:beta-Galactosidase